Zidovudine + lamivudine: new preparation. Fewer tablets required.

  • Published 1999 in Prescrire international
(1) Combivir is a fixed-dose combination of two HIV reverse transcriptase inhibitors: zidovudine (300 mg) + lamivudine (150 mg). (2) A meta-analysis of four trials shows that this combination is more effective clinically than zidovudine monotherapy. One trial also shows that clinical efficacy is even better with the triple combination of the protease… (More)